Bristol Myers Squibb stock rises following FDA approval of its schizophrenia drug

(2:25)

Bristol-Myers CEO Says the Company Is in Transition

(9:5)

The Cell Therapy Process (BMS Cell Therapy Manufacturing Tour)

(3:51)

Trade Tracker: Josh Brown buys Bristol-Myers

(2:55)

Bristol Myers Squibb CEO on cancer drug pipeline

(5:34)

Market's reaction to Alphabet earnings is due to margins, says Gabelli Funds' John Belton

(4:27)

Trade Tracker: Bill Baurch buys Uber as it sells off on soft guidance today

(3:55)

Calls of the Day: Exxon and Robinhood

(5:27)

Trade Tracker: Joe Terranova shares his ETF rebalance strategy and Bryn Talkington buys the ETHA

(5:9)

There are reasons gold will move higher in the long-term, says Permanent Portfolio's Michael Cuggino

(3:26)

DeepSeek security concerns and what people get wrong about the app vs. the model

(1:46)

Perplexity's case for U.S. TikTok ownership

(2:51)

Disney or Amazon could be contenders for second place behind Netflix, says Loop Capital's Alan Gould

(5:17)

Disney's earnings were really solid, says Bank of America's Jessica Reif Erlich

(5:24)

The state of pharmaceuticals: Bristol-Myers Squibb's plan to buy RayzeBio

(2:46)

Bristol Myers Squibb to buy Karuna Therapeutics for $14 billion in cash

(1:42)

Feedback on schizophrenia treatment has been great, says Bristol Myers Squibb CEO

(2:7)

Bristol Myers Squibb - History and Company profile (overview)

(3:18)

Why is Bristol Myers Squibb blocking Americans from accessing more affordable generics?

(1:37)

Bristol Myers Squibb CEO on the latest advances in cancer treatment

(3:6)

NASA's SpaceX CRS-31 Research: Bristol Myers Squibb and Redwire Space

(2:9)

6% Yield Bristol Myers Squibb Value Trap Or Long-Term Opportunity? | FAST Graphs

(26:50)

We got a number of important drugs from the Celgene acquisition, says Bristol Myers Squibb CEO

(7:42)

Our Patient \u0026 Employee Stories: Alicia's Story | Bristol Myers Squibb

(2:54)

Our Patient \u0026 Employee Stories: Matt’s Story | Bristol Myers Squibb

(2:50)

Merck, Bristol Myers and Pfizer...which one is most attractive? #AskHalftime

(4:2)

Bristol Myers Squibb | Patient Stories: Meet Carlos

(6:33)

Bristol Myers Squibb | Global Patient Week 2023: LinkedIn Live

(17:41)